ClinicalTrials.Veeva

Menu

Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 (ECMO-SL-CoV-2)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Covid-19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over the age of 18;
  • Diagnostic COVID-19 by RT-PCR;
  • Hospitalisation in resuscitation for the management of complications related to COVID-19
  • Implanted ECMO-VV or VA during hospitalisation;
  • Patient agreeing to participate in the study

Exclusion criteria

  • Sujet who has expressed opposition to participating in the study.
  • Sujet under guardianship or trusteeship
  • Sujet under safeguard of justice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems